Bioavailability study results for new paediatric tablets for oral suspension, and caution against splitting adult doses
9 September 2006. Related: Conference reports, Paediatric care.
Conference reports
Pharmacokinetic and virological evaluations after stopping NNRTIs in children: a substudy of the PENTA 11 (TICCH) Trial
9 September 2006. Related: Conference reports, Paediatric care.
3TC/abacavir maintains virological superiority over AZT/3TC and AZT/abacavir beyond 5 years in children
9 September 2006. Related: Conference reports, Paediatric care.
French study raises importance of early screening for anal cancer in HIV-positive people
9 September 2006. Related: Conference reports, Coinfections and complications, Cancer and HIV.
Prognostic index for risk of progression of Kaposis Sarcoma
9 September 2006. Related: Conference reports, Coinfections and complications.
Tenofovir did not increase the incidence nephrotoxicity in limited numbers of HIV-positive patients using chemotherapy or HCV-coinfeced patients using ribavirin
9 September 2006. Related: Conference reports, Side effects, Cancer and HIV.
Selected abstracts from Track A presentations at Toronto
9 September 2006. Related: Conference reports, Basic science and immunology.
Use of complementary alternative medicine that could interact with ARV treatment reported by 20% patients in the UK
9 September 2006. Related: Conference reports.
Poor scientific or medical knowledge is a factor in increase in criminal charges for HIV transmission in the UK
9 September 2006. Related: Conference reports.
Treatment access and community responses: online webcasts and debates
9 September 2006. Related: Conference reports, Treatment access.
15th International Drug Resistance Workshop, 13-17 June 2006, Sitges, Spain
3 August 2006. Related: Conference reports, Drug resistance.
Resistance implications of monotherapy with lopinavir/r (Kaletra)
3 August 2006. Related: Conference reports, Drug resistance.
Ritonavir reduces virological failure and resistance in treatment naive patients treated with atazanavir
3 August 2006. Related: Conference reports, Drug resistance.
Resistance to darunavir (TMC-114): predicting responses for treatment experienced patients
3 August 2006. Related: Conference reports, Drug resistance.
Epidemiological studies and transmission of resistance: evidence for optimism or issues with interpretation?
3 August 2006. Related: Conference reports, HIV prevention and transmission, Drug resistance.
K103N containing variants persist longer in women with subtype D and with higher viral loads
3 August 2006. Related: Conference reports, Drug resistance.
No subtype-based differences in baseline levels of K103N-containing variants in women receiving single dose nevirapine
3 August 2006. Related: Conference reports, Drug resistance.
Phenotypic NNRTI resistance and genetic diversity in antiretroviral naive women
3 August 2006. Related: Conference reports, Drug resistance.
High prevalence of the K65R mutation in Botswana patients treated with ddI/d4T-based regimens
3 August 2006. Related: Conference reports, Drug resistance.
Potential for easier selection of K65R mutation with tenofovir pressure in subtype C HIV-1 isolates
3 August 2006. Related: Conference reports, Drug resistance.
Categorisation of transmitted HIV drug resistance using the WHO/CDC HIV drug resistance threshold survey method may be useful in resource limited settings
3 August 2006. Related: Conference reports, Drug resistance.
Limitations in online tools to identify HIV-1 subtypes
3 August 2006. Related: Conference reports, Drug resistance.
Resistance implications from PrEP and microbicide studies in macaques
3 August 2006. Related: Conference reports, Drug resistance.
Low-level resistance linked to treatment failure: a role for more sensitive testing for naive patients
3 August 2006. Related: Conference reports, Drug resistance.
Testing for resistance after starting treatment
3 August 2006. Related: Conference reports, Drug resistance.
7th International Workshop on Clinical Pharmacology of HIV Therapy, 20-22 April 2006, Lisbon
11 June 2006. Related: Conference reports.
Efavirenz levels above recommended upper target in 20% of African patients in Senegal
11 June 2006. Related: Conference reports, Antiretrovirals.
Lower dose of AZT provides adequate exposure in patients with low body weight
11 June 2006. Related: Conference reports, Antiretrovirals.
Pharmacokinetics for generic fixed dose combinations for children are comparable to the branded products
11 June 2006. Related: Conference reports, Paediatric care.
Caution against dividing adult FDCs (Triomune) for young children
11 June 2006. Related: Conference reports, Paediatric care.
University of Liverpool audit of paediatric TDM
11 June 2006. Related: Conference reports, Paediatric care.
Age-dependent pharmacokinetics of 3TC in children
11 June 2006. Related: Conference reports, Paediatric care.
Use of small sample drug level monitoring for paediatric PI concentrations
11 June 2006. Related: Conference reports, Paediatric care.
Intracellular and plasma measurements of AZT and 3TC and their metabolites in neonates
11 June 2006. Related: Conference reports, Paediatric care.
Effect of pregnancy on PK of protease inhibitors
11 June 2006. Related: Conference reports, Pregnancy.
Using enzyme inducers to reduce the half-life of nevirapine
11 June 2006. Related: Conference reports.
Relationship between nevirapine concentrations and virological failure in a clinical setting
11 June 2006. Related: Conference reports, PK and drug interactions.
Summary of drug interaction studies
11 June 2006. Related: Conference reports, PK and drug interactions.
Effects of ketoconazole and rifampin on TMC278
10 June 2006. Related: Conference reports, PK and drug interactions.
Brecanavir interaction study with ritonavir and atazanavir
10 June 2006. Related: Conference reports, PK and drug interactions.
Fixed-dose formulation of efavirenz/tenofovir/FTC bioequivalent to separate dosing
10 June 2006. Related: Conference reports, Antiretrovirals.
Saquinavir/r (1000/100mg) levels reduced when taken fasted and should be taken with food
10 June 2006. Related: Conference reports, Antiretrovirals.
Lack of food effect with Meltrex formulation of lopinavir/r
10 June 2006. Related: Conference reports, Antiretrovirals.
Food interaction reduces ddI intracellular absorption and supports requirement to take fasted
10 June 2006. Related: Conference reports, Antiretrovirals.
Conflicting results on how T-20 affects tipranavir
10 June 2006. Related: Conference reports, Antiretrovirals.
12th Annual Conference of the British HIV Association, 29 March-1 April 2006, Brighton
12 May 2006. Related: Conference reports.
HIV in the UK summaries from BHIVA 12th annual conference
12 May 2006. Related: Conference reports.
Primary care practice still fails to diagnose HIV patients from high-risk groups or with symptomatic acute infection
12 May 2006. Related: Conference reports.
Use of HLA-B*5701 genetic testing to reduce abacavir hypersensitivity reactions
12 May 2006. Related: Conference reports, Side effects.
Dosing rifabutin and lopinavir/r sub-optimal rifabutin levels reported in five patients dosed according to current guidelines
12 May 2006. Related: Conference reports, PK and drug interactions, TB coinfection.
Fatal seronegative visceral leishmaniasis in Portuguese patient
12 May 2006. Related: Conference reports, Coinfections and complications.
Awareness of PEP after sexual exposure (PEPSE)
12 May 2006. Related: Conference reports.
Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
12 May 2006. Related: Conference reports.
Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa
12 May 2006. Related: Conference reports, Side effects.
Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy
12 May 2006. Related: Conference reports.
Causes of death in adults receiving ARV therapy in Senegal
12 May 2006. Related: Conference reports.
Rapid scale-up of treatment in Zambia delivered at primary health level
12 May 2006. Related: Conference reports.
The effect of HIV subtype on disease progression in Rakai, Uganda
12 May 2006. Related: Conference reports.
Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women
12 May 2006. Related: Conference reports, Women's health.
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
12 May 2006. Related: Conference reports, Women's health.
Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load
12 May 2006. Related: Conference reports, Women's health.
Once-daily FTC, ddI, and efavirenz in children and adolescents
12 May 2006. Related: Conference reports, Paediatric care.
Simplified triple NRTI regimen effective in vertically infected children: two years follow-up
12 May 2006. Related: Conference reports, Paediatric care.
Long-term clinical and biological outcomes in children vertically infected with HIV
12 May 2006. Related: Conference reports, Paediatric care.
Prospective follow up of children with lipodystrophy
12 May 2006. Related: Conference reports, Paediatric care.